These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10423634)

  • 1. Hemodynamic effects of a single intravenous infusion of prostaglandin E1 in patients with clinically moderate to severe chronic heart failure.
    Schrader N; Erbel R; Wittlich N; Bannaie M; Gschossmann J; Rink C; Fuchs JB; Dagres N; Mohr-Kahaly S; Meyer J
    Am J Ther; 1997; 4(11-12):381-7. PubMed ID: 10423634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemodynamic effects of a single intravenous administration of prostaglandin E1 in a patient sample with chronic NYHA-stage II/III heart failure].
    Schrader N; Erbel R; Gschossmann J; Rink C; Fuchs JB; Dagres N; Wittlich N; Banaie M; Mohr-Kahaly S; Meyer J
    Z Kardiol; 1998 Sep; 87(9):683-90. PubMed ID: 9816650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of prostaglandin E1 for the treatment of peripheral arterial occlusive disease in patients with congestive heart failure. The Alprostadil Investigators.
    Reisin L; Marmor A; Rabinowitz B; Bernink PJ; Caspi A; Ruzyllo W; Borer JS
    Am J Ther; 1997; 4(11-12):365-74. PubMed ID: 10423632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.
    Pacher R; Globits S; Wutte M; Rödler S; Heinz G; Kreiner G; Radosztics S; Berger R; Presch I; Weber H
    Crit Care Med; 1994 Jul; 22(7):1084-90. PubMed ID: 8026195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prostaglandin E1 on extravascular lung water in patients with severe heart failure.
    Lenz K; Kranz A; Kramer L; Buder R; Schollmayer E
    Am J Ther; 1997; 4(11-12):389-93. PubMed ID: 10423635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-effect relationships of prostaglandin E1 in severe endstage chronic heart failure.
    Stanek B; Pacher R
    Jpn Heart J; 1997 Jan; 38(1):53-65. PubMed ID: 9186281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiodynamic improvement following PGE1 administration in sheep with congestive heart failure.
    Schutte PJ; du Plooy WJ
    Prostaglandins Leukot Essent Fatty Acids; 1990 Sep; 41(1):45-9. PubMed ID: 2251296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
    Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.
    Zhao L; Lu J; Wang C; Zhao W; Qing E; Ma J
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1208-11. PubMed ID: 24090805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.
    Slawsky MT; Colucci WS; Gottlieb SS; Greenberg BH; Haeusslein E; Hare J; Hutchins S; Leier CV; LeJemtel TH; Loh E; Nicklas J; Ogilby D; Singh BN; Smith W
    Circulation; 2000 Oct; 102(18):2222-7. PubMed ID: 11056096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined hemodynamic echocardiographic Doppler evaluation of prostaglandin E1 effects in patients with severe dilated cardiomyopathy undergoing evaluation for heart transplantation.
    Barbieri E; Perini P; Marino P; Zardini P
    J Heart Lung Transplant; 1995; 14(3):572-8. PubMed ID: 7654741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
    Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
    Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil Investigators.
    Somberg JC; Yelamanchi V; Molnar J; Aschermann M; Bernink PJ; Caspi A; Marmor A; Rabinowitz B; Reisin L; Ruzyllo W
    Am J Ther; 1997; 4(11-12):401-4. PubMed ID: 10423637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of small doses of prostaglandin E(1) on systemic hemodynamics and jugular venous oxygen saturation during cardiopulmonary bypass.
    Kadoi Y; Saito S; Goto F; Fujita N
    J Clin Anesth; 2001 Sep; 13(6):417-21. PubMed ID: 11578884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of creatine phosphate in patients with congestive heart failure: a double-blind comparison trial versus placebo.
    Ferraro S; Codella C; Palumbo F; Desiderio A; Trimigliozzi P; Maddalena G; Chiariello M
    Clin Cardiol; 1996 Sep; 19(9):699-703. PubMed ID: 8874988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
    Khalife K; Zannad F; Brunotte F; Belhadj K; Juilliere Y; Iannascoli F; Gilgenkrantz JM
    Am J Cardiol; 1987 Aug; 60(5):75C-79C. PubMed ID: 2956874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prostaglandin E1 infusion in severe chronic heart failure.
    Pacher R; Stanek B; Hülsmann M; Sinzinger H
    Prostaglandins; 1997 Apr; 53(4):221-35. PubMed ID: 9167210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous intravenous infusion of prostaglandin E1 improves myocardial perfusion reserve in patients with ischemic heart disease assessed by positron emission tomography: a pilot study.
    Huang CL; Wu YW; Wang SS; Tseng CD; Chiang FT; Hsu KL; Lee CM; Tzen KY
    Ann Nucl Med; 2011 Aug; 25(7):462-8. PubMed ID: 21461596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.